BURNABY, British Columbia, Sept. 10, 2018 (GLOBE NEWSWIRE) -- Xenon Pharmaceuticals Inc. (Nasdaq:XENE), a clinical stage, neurology-focused ... read more
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program
Xenon Enters into Agreement to Buy Out Milestones and Royalties Related to its XEN1101 Program